Science Current Events | Science News | Brightsurf.com
 

Research shows how 'Mallard' dye fills need for speed

February 15, 2013

Scientists at the University of York have developed a new medical tool which could help surgeons carrying out complex procedures in the operating theatre.

Researchers have developed a dye which provides a quick and accurate method of checking heparin levels in the blood.

Heparin is an important anti-coagulant which has a significant role in major surgery. The scientists in the Department of Chemistry at York have used inspiration from biological systems to allow the dye to bind heparin even in highly competitive human serum.

In the laboratory, they have modified existing dyes which previously could not bind with heparin successfully under these challenging conditions. The modified dye, which has excellent sensing capacity for heparin pinpoints the anti-coagulant's level in human serum and has the potential to work more quickly than existing clinical methods for doing this.

The research, which was funded by the Biotechnology and Biological Sciences Research Council, is published in the Journal of the American Chemical Society.

Because the dye can rapidly detect heparin levels, the scientists have named it 'Mallard Blue'. It is the same shade as the livery of the A4 Pacific Mallard, which holds the world speed record for a steam locomotive, and is now preserved at the National Railway Museum in York.

Professor Dave Smith, of the Department of Chemistry at York who led the research said: "Our new dye allows the quantification of heparin in serum at clinically relevant levels and is the best in class for this application in terms of its ability to bind heparin strongly under really competitive biological conditions, and may improve on the currently used systems.

"We have named the dye 'Mallard Blue', after the record-breaking steam train, 'Mallard' which is housed in the railway museum here at York. Our dye is the same colour as the locomotive, and we believe it is similarly ground-breaking in its performance."

The York researchers worked with a team led by Sabrina Pricl at the University of Trieste who used high-level computer modelling to understand precisely how Mallard Blue binds to heparin so strongly.

The next stage in this research would involve the incorporation of this new dye into a device for simple bedside read-out of heparin levels in blood.

University of York


Related Heparin Current Events and Heparin News Articles


Anticoagulation medications show no gender-based variations in outcomes for TAVR patients
A study on the impact of using different anticoagulation medications on men and women who have undergone a transcatheter aortic valve replacement (TAVR) found no difference in early vascular complications or mortality.

Snake venom could make surgery safer for patients on blood thinners
Preventing blood clots with drugs such as heparin has become a common practice for fighting some heart and lung conditions, and for certain surgeries.

Snake venom helps hydrogels stop the bleeding
A nanofiber hydrogel infused with snake venom may be the best material to stop bleeding quickly, according to Rice University scientists.

Treatment for heparin-induced blood disorder revealed in structure of antibody complex
A potential treatment for a serious clotting condition that can strike patients who receive heparin to treat or prevent blood clots may lie within reach by elucidating the structure of the protein complex at its root, according to new research from the Perelman School of Medicine at the University of Pennsylvania.

McMaster hematologist identifies different limb loss syndromes
How people can develop limb gangrene and lose fingers and feet has baffled doctors for centuries.

Lower risk treatment for blood clots 'empowers' patients, improves care
Potentially fatal blood clots account for thousands of emergency room visits each year and often those patients are admitted to the hospital, treated with an injectable anticoagulant and monitored for a few days.

Heart patients can stop blood thinners when undergoing elective surgery
Patients with atrial fibrillation who stopped taking blood thinners before they had elective surgery had no higher risk of developing blood clots and less risk of major bleeding compared to patients who were given a "bridge" therapy, according to research led by Duke Medicine.

Statewide quality improvement program helps lower rates of trauma complications
As health insurers place more emphasis on paying for quality outcomes rather than for specific services provided by doctors and hospitals, several quality improvement programs have been developed as a way to help health care providers identify problem areas and share best practices.

Low stent thrombosis rates with primary PCI, regardless of antithrombotic choice
Stent thrombosis following urgent angioplasty for acute heart attack occurred in less than 1% of patients in a large, "real-world" registry, regardless of whether the antithrombotic treatment used during the procedure was bivalirudin, heparin alone, or a GP IIb/IIIa inhibitor (typically in combination with heparin).

New studies examine the significant risk of blood clots in post-surgical lung cancer patients
One life-threatening complication of lung cancer surgery is the formation of blood clots in the lungs (also called pulmonary embolism - PE) or in the legs (also known as deep vein thrombosis - DVT).
More Heparin Current Events and Heparin News Articles

Practical Hemostasis and Thrombosis

Practical Hemostasis and Thrombosis
by Nigel S. Key (Editor), Michael Makris (Editor), David Lillicrap (Editor)


Designed as a practical, succinct guide, for quick reference by clinicians with everyday questions, this title guides the reader through the range of approaches available for diagnosis, management, or prevention of hemorrhagic and thrombotic diseases or disorders.
Provides essential practical management for all those working in the field of hemostasis and thrombosis  Includes new chapters on direct oral anticoagulants, acquired inhibitors of coagulation, and expanded discussion of thrombotic microangiopathies Covers in a clear and succinct format, the diagnosis, treatment and prevention of thrombotic and haemostatic disorders Follows templated chapter formats for rapid referral, including key points and summary boxes, and further reading Highlights controversial issues and...

Heparin - A Century of Progress (Handbook of Experimental Pharmacology)

Heparin - A Century of Progress (Handbook of Experimental Pharmacology)
by Rebecca Lever (Editor), Barbara Mulloy (Editor), Clive P. Page (Editor)


Heparins remain amongst the most commonly used drugs in clinical practice.  Almost 100 years have passed since the initial discovery of this complex substance and, during this time, understanding of the nature and uses of heparin and related molecules has grown dramatically. The aim of this volume is to summarise the developments that have led to the current status of both heparins as drugs and the field of heparin research, with a focus on the particularly rapid progress that has been made over the past three decades. Individual sections are dedicated to the nature of heparin as a biological molecule, the current approaches and techniques that are used to ensure the safety and reliability of heparin as a medicine, the clinical pharmacology of heparin as an anticoagulant drug, effects...

Heparin

Heparin


Heparin

Target audience: Medical students, residents, healthcare workers, patients
Weekly updates? Yes
Multiple choice questions? Yes
Board review? Yes

Heparin Induced Thrombocytopenia (HIT)

Heparin Induced Thrombocytopenia (HIT)


Heparin Induced Thrombocytopenia (HIT)

Target audience: Medical students, residents,
Multiple choice questions? Yes
Weekly updates? Yes
Board review? Yes. Including USMLE, ABSITE, etc.

Heparin-Induced Thrombocytopenia, Fourth Edition: (Special Edition for GSK)

Heparin-Induced Thrombocytopenia, Fourth Edition: (Special Edition for GSK)
by Theodore Warkentin (Editor), Andreas Greinacher (Editor)


Although first reported in 1973, immune heparin-induced thrombocytopenia (HIT) remains one of the most potentially devastating and frequent adverse drug reactions encountered by physicians. This Fourth Edition reinforces its standing as the leading guide to the accurate diagnosis and management of HIT by identifying key signs and symptoms of this disorder and providing clear intervention strategies, including detailed information on the use of alternative anticoagulants to manage these critical circumstances. Intended for those requiring an expert source of guidance for the quick detection and control of HIT, this reference: contains new chapters on novel pharmacotherapies, recent drug approvals, current dosing guidelines, and the advantages and limitations of alternative...

Heparin-Induced Thrombocytopenia: An Update

Heparin-Induced Thrombocytopenia: An Update
by Applied Research Press (Author)


Heparin-induced thrombocytopenia (HIT) is the most important and most frequent drug-induced, immune-mediated type of thrombocytopenia. It is associated with significant morbidity and mortality if unrecognized. In this review, we briefly discuss the main features of heparin-induced thrombocytopenia, particularly analyzing the most recent advances in the pathophysiology, diagnosis and treatment of this syndrome. Proceeds from the sale of this book go to the support of an elderly disabled person.

Heparin-Binding Proteins

Heparin-Binding Proteins
by H. Edward Conrad (Author)


This book describes the complex structures of heparins and heparan sulfates (heparinoids) and how they are generated by their biosynthetic pathways. The book also details the methodologies for studying these structures and their cellular metabolism. Heparin-Binding Proteins introduces the general nature of interactions between heparinoids and proteins, and presents the role for these structures in their interactions with the proteins of the hemostatic mechanisms, fibroblasts growth factors, superoxide dismutase, and lipoproteins.

Key Features
* Covers cellular metabolism of heparinoid proteoglycans
* Written by a distinguished expert in the field of carbohydrate biochemistry
* Describes the roles of heparan sulfate proteoglycans...

The 2018-2023 World Outlook for Low Molecular Weight Heparin (LMWH)

The 2018-2023 World Outlook for Low Molecular Weight Heparin (LMWH)
by Icon Group International (Author)


This study covers the world outlook for low molecular weight heparin (LMWH) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized...

Heparin-Induced Thrombocytopenia, Fifth Edition (Fundamental and Clinical Cardiology)

Heparin-Induced Thrombocytopenia, Fifth Edition (Fundamental and Clinical Cardiology)
by Theodore E. Warkentin (Editor), Andreas Greinacher (Editor)


Although first reported in 1973, immune heparin-induced thrombocytopenia (HIT) remains one of the most frequent and devastating adverse drug reactions encountered by physicians. This thoroughly updated fifth edition from international experts Professors Warkentin and Greinacher is the gold standard for accurate diagnosis and management of this condition. Identifying key signs and symptoms and providing clear intervention strategies―including the use of alternative anticoagulants to manage critical circumstances―this is an essential resource for all clinicians and a "must" for hematology consultants. Heparin-Induced Thrombocytopenia, Fifth Edition explores: Clinical and laboratory studies on HIT The immune basis and pathogenesis, animal models, and laboratory testing for HIT...

Heparin: Structure, Drug Delivery Applications and Clinical Outcomes (Pharmacology-Research, Safety Testing and Regulations)

Heparin: Structure, Drug Delivery Applications and Clinical Outcomes (Pharmacology-Research, Safety Testing and Regulations)
by Nicole B. Wilkinson (Editor)




© 2017 BrightSurf.com